Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, April 11, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of America’s...
-
Week 64 showed unprecedented progress toward establishing a common understanding by working things out for lasting peace.
-
NEW YORK, April 11, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of PennyMac...
-
Did you buy PYPL common stock between February 8, 2024, and February 2, 2026? Affected PayPal Holdings, Inc. Investor Summary Who: PayPal Holdings, Inc. (NASDAQ: PYPL)What: Securities fraud class...
-
Did you buy GEMI Class A common stock and/or securities between September 12, 2025, and February 17, 2026? Affected GEMI Investor Summary Who: Gemini Space Station, Inc. (NASDAQ: GEMI)What:...
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Eos (EOSE) To Contact Him Directly To Discuss Their Options If you purchased or...
-
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd....
-
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Kyndryl Holdings, Inc. (NYSE: KD) between August 7, 2024...
-
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that it has filed a securities class action lawsuit on February 20, 2026 in the United States District Court for...
-
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between June...